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ABSTRACT 
The term “phyto” means plant while “some” means cell-like. Phytosome is novel emerging technique applied to phyto-pharmaceutical which 
contains phytoconstituents to herbal extract surrounds and bound by lipids. Phytosome shows better absorption, hence produces better 
bioavailability than the conventional herbal extracts. Because of their improved pharmacological and pharmacokinetic properties. Phytosomes 
are herbal formulation which has enhanced the therapeutic effects of the plant extracts and herbal lead molecule by increasing bioavailability in 
the target site compared to conventional herbal extracts. This is improved forms of herbal formulation which contain the bioactive 
phytoconstituents of herb essence enclosed and bound by a lipid. Phytosomes demonstrated improved pharmacokinetic and pharmac odynamic 
response than customary botanical extracts.   
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Introduction of phytosomes: 
Phytosomes is a complex of a phospolipid and natural active 
ingredients. It is claimed that phytosome increases 
absorption of "conventional herbal extracts" or isolated 
active principles both topically  as well as orally. Hydrophilic 
phytoconstituents can be complexed with clinically useful 
nutrients such as phospholipids to convert them into lipid 
soluble complexes. Such complexes can be used to prepare 
liposome-like vesicles called as phytosomes(1,2).  
In phytosomes, the complexation of phospholipids and 
water soluble active plant components involve chemical 
bond formation and therefore more stable. The phytosomes 
substantially improve the bioavailability of these hydrophilic 
active components. Some of the phospholipids that are 
reported for phytosome preparation include soy 
phospholipids, phosphodidylcholine etc. Phytosomes can 
easily cross the lipid membranes and are reported to 
increase the bioavailability of poorly lipid soluble plant 
based drugs by increasing the absorption in gastrointestinal 
tract. 
Phytosome is also called as Phytolipids delivery system 
which forms a bridge between the conventional delivery 
system and novel delivery system. The term "phyto" means 
plant while "some" means cell-like. The phytosomes 
technology produces a little cell, whereby the plant extract 
or its active constituent is protected from destruction by 
gastric secretions and gut bacteria owing to the gastro-
protective property of phosphatidylcholine. Most of the 
bioactive constituents of phytomedicines are water-soluble 
molecules (e.g. phenolics, glycosides, and flavonoids). 
However, water-soluble phytoconstituents are limited in 
their effectiveness because they are poorly absorbed when 
taken orally or when applied topically (3).Phytosomes are 
not liposomes - structurally, the two are distinctly different 
as shown in Fig. The phytosome is a unit of a few molecules 
bonded together, while the liposome is an aggregate of many 
phospholipid molecules that can enclose other phytoactive 
molecules but without specifically bonding to them. 
Liposomes are touted delivery vehicles, but for dietary 
supplements their promise has not been fulfilled.But for 
Indena’s phytosome products numerous studies prove they 
are markedly better absorbed and have substantially greater 
clinical efficacy.(4,5) Phytosomes are advanced forms of 
herbal products that are better absorbed, utilized, and as a 
result produce better results than conventional herbal 
extracts. Phytosome is a complex between a natural product 
and natural phospholipids, like soy phospholipids. Such a 
complex is obtained by reaction of stoichiometric amounts 
of phospholipid and the substrate in an appropriate 
solvent.They are miscible both in water and in oil/ lipid 
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environments, and are well absorbed orally. Phospholipids 
are small lipid molecules in which the glycerol is bonded 
only to two fatty acids, instead of three as in triglycerides, 
with the remaining site occupied by a phosphate group. The 
phospholipids mainly employed to make phytosomes, is 
phosphatidylcholine, derived from soybean (Glycine max). 
The phytosome process has been applied successfully too 
many popular herbal extracts including Ginkgo biloba, grape 
seed, hawthorn, milk thistle (Silybummarianum), green tea 
(Theasinensis) and ginseng (Panax ginseng). The flavonoids 
and terpenoids components of these herbal extracts are able 
to directly bind to phosphatidylcholine. (6, 7)  
Common Drug Delivery Systems used in 
Pharmaceutical technology: 
The “Somes” the cell like formulations of novel drug delivery 
system. There are different types of somes like 
Liposomes. Liposomes are nano size artificial vesicles of 
spherical shape that can be produced from natural 
phospholipids and cholesterol. 
Herbosomes: Herbosomes are purified phytochemical 
extracts complexed with phospholipids for a better 
bioavailability and enhanced biological activities. 
Cubosomes: Cubosomes are nanoparticles but instead of the 
solid particles, cubosomes are self-assembled liquid 
crystalline particles of certain surfactant with proper ratio of 
water with a microstructure that provides unique properties 
of practical interest. 
Colloidosomes: Colloidosomes are solid microcapsules 
formed by the self assembly of colloidal particles at the 
interface of emulsion droplets which are hollow, elastic 
shells whose permeability and elasticity can be precisely 
controlled. 
Ethosomes: Ethosomes are noninvasive delivery carriers 
that enable drugs to reach the deep skin layers and/or the 
systemic circulation. They contain phospholipids, alcohol 
(ethanol and isopropyl alcohol) in relatively high 
concentration and water. 
Aquasomes: Aquasomes are spherical 300nm particles used 
for drug and antigen delivery. The particle core is composed 
of noncrystalline calcium phosphate or ceramic diamond, 
and is covered by a polyhydroxyl oligomeric film. 
Aquasomes were prepared by self-assembling of 
hydroxyapatite by co-precipitation method and thereafter 
preliminary coated with polyhydroxyl oligomers (cellobiose 
and trehalose) and subsequently adsorbed with bovine 
serum albumin (BSA) as a model antigen. BSA-immobilized 
aquasomes were around 200 nm in diameter and spherical 
in shape and had approximately 20-30% BSA-loading 
efficiency. 
Pharmacosomes: pharmacosomes are pure drug vesicles 
formed by the amphiphilic drugs. Any drug possessing a free 
carboxyl group or an active hydrogen atom (–OH, NH2) can 
be esterified (with or without a spacer group) to the 
hydroxyl group of a lipid molecule, thus generating an 
amphiphilic prodrug. The amphiphilic prodrug is converted 
to pharmacosomes on dilution with water. 
Niosomes: Niosomes are non-ionic surfactant vesicles and, 
as liposomes,are bilayered structures. Niosomes present low 
production cost, greater stability, andresultant ease of 
storage.Niosomes are chemically stable, can entrap both 
lipophilic and hydrophilic drugs either inaqueous layer or in 
vesicular membrane and present lowtoxicity because of 
their non-ionic nature. 
Proniosomes: Proniosomes are dry formulations of 
surfactant-coated carrier, which can be measured out as 
needed and rehydrated by brief agitation in hot water. 
 
Fig no: 1 Difference between phytosomes and liposomes. 
The molecular organization of phytosomes (lower 
segment) liposome (upper segment) 
Benefits of Phytosomes (8): 
1. There is a dramatic enhancement of the bioavailability of 
botanical extracts due to their complexation with 
phospholipid and improved absorption in the intestinal 
tract.  
2. They permeate the non-lipophilic botanical extract to 
allow better absorption from the intestinal lumen, which is 
otherwise not possible.  
3. The formulation of Phytosome is safe and the components 
have all been approved for pharmaceutical and cosmetic use. 
 4. They have been used to deliver liver protecting flavonoids 
because they can be made easily bioavailable by 
phytosomes. In addition to this, Phosphatidylcholine is also 
hepatoprotective and so provides a synergistic effect for 
liver protection.  
5. This technology offers cost effective delivery of 
phytoconstituents and synergistic benefits when used as 
functional cosmetics to protect the skin against exogenous 
or endogenous hazards in normal as well as stressful 
environmental conditions.  
6. They can be also used for enhanced permeation of drug 
through skin for transdermal and dermal delivery.  
7. These are platform for the delivery of large and diverse 
group of drugs (peptides, protein molecules).  
8. The vesicular system is passive, non-invasive and is 
available for immediate commercialization.  
9. Phosphatidylcholine, an essential part of the cell 
membrane used in phytosome technology, acts as a carrier 
and also nourishes the skin.  
10. There is no problem with drug entrapment during 
formulation preparation. Also, the entrapment efficiency is 
high and moreover predetermined; because the drug itself 
forms vesicles after conjugation with lipid.  
11. They offer a better stability profile because chemical 
bonds are formed between the phosphatidylcholine 
molecules and Phytoconstituents.  
12. The dose requirement is reduced due to improved 
absorption of the main constituent. They can also be given in 
smaller quantities to achieve the desired results.  
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13. Low risk profile: This technology has no large-scale drug 
development risk since the toxicological profiles of the 
phytosomal components are well documented in the 
scientific literatures.  
14. Relatively simple to manufacture with no complicated 
technical investment required for the production of 
Phytosomes. 
15.They transport from cell membrane and enter the cell 
membrane easily. 
16.Phytosomes proves to be of significantly greater clinic 
benefits. 
17.Facilities liver targeting by increasing the solubility in 
bile salts. 
18.The required dose is reduced as the absorption of the 
active phyto constituents is improved. 
19.Phytosomes improve transdermal absorption of 
phytoconstituents. 
20.Phytosomes are widely used in cosmetic due to improved 
skin penetration and high lipid profile. 
21.Valuable component of herbal extracts are protected 
from destruction by digestive ecretion and gut bacteria. 
22.It assure proper delivery of drug respective tissues. 
23.Phospotidylcholine used in preparation of phytosomes; 
besides acting as carrier also act as hepato protective as 
result it improve a synergistic effects. 
24.Phospotidylcholine used in formulating phytosomes 
process besides actng as carrier also nourishes the skin as it 
is an essential part of a cell membrane. 
25.Phytosomes are also superior to liposomes in skin care 
products. 
26.phytosomes show better stability profile due to 
formation of chemical bonds between phospotidylcholine 
molecules & phytoconstituents. 
27.Phytosomes insure increased duration of action for 
herbal drugs. 
28. Phytosomes are used in preparation of phytosomes , 
besides acting as carrier also act as hepatoprotective , gives 
synergistic effects. 
 
Difference between phytosomes and liposomes 
Table 1:-Difference between phytosomes and liposomes 
Phytosomes Liposomes 
Phytosome is a unit of a molecules bounded together. 
Liposome is an aggregate of many phospholipid molecules 
that can enclose other phytoactive molecules but without 
specifically bonding to them. 
Phytosome process the phosphatidylcholine and the plant 
components actually form a 1:1 or a 2:1 molecular complex 
depending on the substances complexed. Involving 
chemical bonds. So they better absorbed and shown better 
bioavability. 
In liposome no chemical bond is formed. The 
phosphtidylcholine molecules surround the water soluble 
substance. There may be hundereds or even thousands of 
phosphtidylcholine molecules surrounding the water 
soluble compound. 
Phytosome complex can somewhat be compared to an 
integral part of the lipid membrane. Where the polar 
functionalities of the lipophilic guest interact via hydrogen 
bonds with the polar head of a phospholipids (i.e. 
phosphate and ammonium groups). Forming a unique 
pattern which can be characterized by spectroscopy. 
In liposomes. The active principles are dissolved in the 
central part of the cavity. With no possibility of molecular 
interaction between the surrounding lipid and hydrophilic 
substance. 
Phytosomes act with the solvent having a reduced 
dielectric constant such as Acetone, Dioxane, 
Metyhlenechloride, Hexane and Ethyl acetate etc. 
Liposomal drug complex is formed in the presence of the 
water or buffer solution. 
 
PROPERTIES OF PHYTOSOMES (9): 
1. Chemical properties 
Phytosomes is a complex between a natural product and 
natural phospholipids, like soy phospholipids which is 
obtained by reaction of stoichiometric amounts of 
phospholipid and the substrate in an appropriate solvent. It 
is confirmed by the spectroscopic analysis that the main 
phospholipid-substrate interaction is due to the formation of 
hydrogen bonds between the polar head of phospholipids 
(i.e. phosphate and ammonium groups) and the polar 
functionalities of the substrate. Phytosomes assumes a 
micellar shape forming liposomial-like structures in the 
presence of water. 
2. Biological Properties 
Phytosome, as an advanced form of herbal product is better 
absorbed, utilized and as a result produces better results 
than conventional herbal extract. The increased 
bioavailability of the phytosome over the non complexed 
botanical derivatives has been explained and verified by 
various pharmacokinetics and pharmacodynamic tests on 
experimental animal models and on human subjects(9).  
Phospholipids  
Phospholipids are small lipid molecules where glycerol is 
bonded to two fatty acids, while the third hydroxyl,  normally 
one of the two primary  methylenes, bears a phosphate 
group bound to a biogenic amino or to an amino acid. 
Phospholipids are a class of lipids and are a major 
component of all cell membrane. In humans and other higher 
animals the  phospholipids  are  also  employed  as  natural  
digestive  aids  and  as carriers  for  both  fatmiscible  and  
water  miscible  nutrients.  They  are  miscible  both  in water  
and  in  lipid  environments,  and  are  well  absorbed  orally.  
Phospholipids from soybean, (Glycine  max) mainly  
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phosphatidylcholine  is  a  lipophilic  agent  that  readily 
complex  polyphenolics  and  widely  employed  to  make  
phytosomes. Phosphatidylcholine,  the  major  molecular  
building  block  of  cell  membranes  is  a compound miscible 
in both water and in oil/lipid environments. (10,11)  
 
Table 2 :-Phospholipids 
Natural phospholipids Synthetic phosholipids 
PC - Phosphatidyl choline DOPC - Dioleoyl Phosphatidylcholine 
PE- Phosphatidyl ethanolamine DOPE - Dioleoyl phosphatidyl ethanolamine 
PS - Phosphatidyl serine DSPC - Distearoyl phosphatidyl choline 
 DSPE - Distearoyl phosphatidyl ethanolamine 
 DLPC - Dilauryl phosphatidyl choline 
     
COMPLEXING AGENTS IN PHYTOSOMES: 
Phospolipids are lipids containing phosphorous and a polar 
portion and non polar portion in their structure. 
Phospolipids are abundant in egg yolk &plant 
seeds.phospolipids can be depend on backbone is divided 
into two types. 
1. Glycerophospolipids 
2. Sphingomyelins  
1. Glycerophospolipids  
1) Phospatidylcholine (PC) or Lecithin  
2) Phospatidylethanolamine (PE)  Cephalin 
3) Phospatidylserine (PS) 
4) Phospatidic acids (PA) or Phospatidate 
5) Phospatidylinositol (PI) 
6) Phospatidylglycerol (PG) 
7) Cardiolipin (CL) 
PC,PE & PS are major phospholipids used to prepare 
complexes that are composed of hydrophilic head group & 
two hydrophobic hydrocarbon chains. PC is most frequently 
used to prepare phospolipid complexes. Benefits of PC is 
Amphipathic property gives solubility in water and lipid 
media.It exhibits robust biocompatibility & low toxicity.PC is 
essential components of cell membranes. PC molecules 
exhibits Hepatoprotective activity & clinical effects is shown 
treatment of liver disease,Hepatitis,Fatty liver & 
Hepatocirrhosis.Phyto-phospolipid complex can not only 
improve solubility of lipophilic polyphenols in aqueous 
phase but also membrane penetrability of hydrophilic ones 
from aqueous phase. 
PC is an important substrate of synthesis of the 
neurotransmitter acetylcholine, and having the function of 
nourishing the brain and improving intelligence . 
PE is a playing an important role in membrane fusion . 
PS is a improving function of nerve cells, regulating the 
conduction of nerve impulse, and enhancing the memory 
function of brain . The common feature of apoptosis . The 
main acidic phospholipids of membranes of platelets, and 
involved in the clotting process .  
PI is the precursor of second messenger, which plays a very 
important role in the process of transmission of messages in 
neural system .  
CL is a phospholipid of unusual structure is localized almost 
exclusively to inner mitochondrial membrane, is particularly 
rich in unsaturated fatty acids. This phospholipid plays an 
important role in mitochondrial bioenergetics by affecting 
the activity of key proteins of mitochondrial inner 
membrane .  
SM is along with cholesterol, constituting the key 
components of the stable, detergent-resistant nanodomains 
in membranes, called functional lipid rafts which have been 
identiﬁed as the important membrane structure of signal 









Structure of phospotidylcholine (PC)  
 
Fig 2:-Structure of phospotidylcholine (PC) 
PC is a phospholipids attached to choline particle. 
phospolipids contains fatty acids, glycerol ,and 
phosphorous.the phosphorous part of phospholipids 
substance –the lecithin –is made up of PC. PC is chemical 
contained in eggs, soyabean mustard , sunflower & 0other 
foods. PC are used for treating hepatitis, eczema, gall bladder 
disease, circulation problems,high cholesterol and 
premenstrual syndrome; for improve  effectiveness of 
kidney dialysis; for boosting the immune system & for 
preventing aging. healthcare providers sometimes gives the 
phospotidylcholine intravenously(IV) for chest pain , fat 
globules in the blood (fat embolism),high cholesterol , liver 
disease & fatty plaque deposits in arteries. PC is injected 
under the skin (subcutaneously) for treating non-cancerous 
fatty tumors (lipomas), excess fat around eyelids & yellowish 
cholesterol deposits just under surface of skin 
(xanthelasmas). Phosphatidylcholines (PC) are a class 
of phospholipids that incorporate choline as a headgroup. 
They are a major component of biological membranes and 
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can be easily obtained from a variety of readily available 
sources, such as egg yolk or soybeans, from which they are 
mechanically or chemically extracted using hexane. They are 
also a member of the lecithin group of yellow-brownish fatty 
substances occurring in animal and plant tissues. 
Dipalmitoyl phosphatidylcholine (a.k.a. lecithin) is a major 
component of pulmonary surfactant and is often used in 
the L/S ratio to calculate fetal lung maturity. While 
phosphatidylcholines are found in all plant and animal cells, 
they are absent in the membranes of most 
bacteria,including Escherichia coli. Purified 
phosphatidylcholine is produced commercially. 
Uses of phospotidylcholine: 
1. Inflammatory bowel disease (ulcerative colitis). 
Research suggests that taking various types of 
phosphatidylcholine daily for up to 3 months improves 
symptoms in people with ulcerative colitis. 
2. Hepatitis A. Taking phosphatidylcholine by mouth does 
not seem to improve liver function in people with 
hepatitis A. 
3. Infant development. Taking phosphatidylcholine during 
pregnancy does not seem to improve the brain 
development of the infant. 
4. Improving a medical procedure called peritoneal 
dialysis. Taking phosphatidylcholine by mouth does not 
seem to improve a medical procedure called peritoneal 
dialysis. 
5. A movement disorder called tardive dyskinesia. 
Taking phosphatidylcholine by mouth does not seem to 
improve a movement disorder called tardive dyskinesia. 
6. Acne. Early research suggests that applying a cream 
containing 4% niacinamide and phosphatidylcholine to 
the skin seems to improve acne in some people. 
7. Liver disease caused by alcohol. Early research 
suggests that taking phosphatidylcholine daily for 24 
months does not increase survival in people with liver 
disease caused by drinking alcohol. 
8. Reducing fat deposits. Early research suggests that 
injections of phosphatidylcholine under the skin may 
make fatty deposits on the chin, thigh, hips, abdomen, 
back, neck, and elsewhere look smaller to some people. 
Improvements appear to last for 2-3 years or longer. In 
one study, 80% of patients reported improvements in 
facial fat that lasted for up to 3 years. However, these 
results have been questioned because the studies were 
not well designed. 
9. Declining brain function caused by liver disease. 
Research suggests that taking phosphatidylcholine daily 
for 6-8 weeks does not improve declining brain function 
in people with liver disease or liver failure. 
10. Hepatitis B. Studies regarding hepatitis B show 
conflicting results. It is not clear if phosphatidylcholine is 
beneficial. 
11. Hepatitis C. Early research suggests that taking 
phosphatidylcholine by mouth, together with interferon, 
seems to improve liver function in people with hepatitis 
C. 
12. Inability to break down cholesterol in the body. Early 
research suggests that taking phosphatidylcholine does 
not reduce cholesterol levels in the body of people who 
are unable to break down cholesterol 
13. Treating non-cancerous fatty tumors (lipomas). 
There is one report that injecting a phosphatidylcholine 
solution directly into a lipoma can shrink the tumor by 
about 35%. However, this treatment might cause an 
unwanted reaction in the lipoma.  
14. Liver disease not related to alcohol use (nonalcoholic 
fatty liver disease; NAFLD). Early research suggests 
that taking a product containing phosphatidylcholine, 
along with vitamin E, and silybin, a chemical in milk 
thistle might improve liver function in people with the 
liver disease known as NAFLD.  
15. Memory loss. There is early evidence that taking a single 
25 mg dose of phosphatidylcholine can improve some 
measures of memory in healthy college students. 
16. Eyelid fat. There is some evidence that injecting a 
phosphatidylcholine solution reduces bulging lower 
eyelid fat pads in some people.  
17. Anxiety. 
18. Eczema. 
19. Gallbladder disease. 
20. Manic-depressive illness. 
21. Circulation disorders of the arms and legs. 
22. Weight loss. 
23. Premenstrual syndrome (PMS). 
24. Alzheimer's disease. 
25. Depressed immunity. 
26. Preventing aging. 
2. Sphingomyelin (SM) 
All SM of biological sources are D-erythro 
configuration.SM are important component of animal cell 
membranes. PC &SM are very similar in molecular structure 
they have some differences. The  backbone of SM is 
sphingosine. The backbone of PC is glycerol. 
 
Table 3:-Sphingomyelin (SM) 
S. N. Phospotidylcholine ( PC) Sphingomyelin (SM) 
1) The backbone of PC is Glycerol. The backbone of SM are Sphingosine. 
2) 
Each PC molecule average contains 1.1-1.5 cis –double 
bonds. 
Each SM molecule average contains 0.1-0.35 cis -
double bonds in amide linked acyl chains. 
3) 
Saturation of hydrophobic regions of PC is less than that of 
SM. 
Saturation of hydrophobic regions of SM  is higher 
than that of PC. 
4) The  PC are symmetric molecules. The SM are asymmetric molecules. 
5) 
The typical contaian moderate length (16-18) of acyl chains 
and length of two chains are approximately equal. 
The  typical acyl length of naturally occurring SM 
are usually more than 20,while the paraffin 
residue of Sphingosine are relatively shorter. 
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Method of preparation: (12,13,14) 
2.1 solvent evaporation method- 
plant material + phospolipid  100 ml of RBF 20 ml acetone 
 50 ºc, 2 hrs 
                                                                                                                 
                                                                                                                                    5-10 ml precipitate filter collect 
                                                                                                                                     
Dried precipitate phytosomes amber bottle  store  at R.T. 
                                             
2.2 Rotary evaporation method - 
Plant material + phospolipid  dissolve 30 ml of tetrahydrofuran                      100 ml of rotary RBF 
  
 3 hrs stir,40ºc 
     Thin film  obtained 
   Collect ppt & amber bottle store R.T.                                         stirr with magnet                                   n-hexane add 
 
 
2.3 Anti-solvent precipitation technique- 
Plant material + phospolipid  100 ml RBF  20 ml di-chloromethane 
 60 ºc,2 hrs 
                                                                                                                             20 ml ppt add n-hexane 
 
      Powder complex  in amber bottle                                100  #  sieved        Filter dried & crush 
 
CHARACTERIZATION TECHNIQUES OF 
PHYTOSOME (15,16,17)    
3.1 Visualization: Visualization of phytosomes can be done 
using transmission electron microscopy (TEM) and by 
scanning electron microscopy (SEM).(18).    
SEM was used to determine the size of the particle and its 
appearance. Dry sample was placed on electron microscope 
brass stub coated with gold in an ion sputter. Random 
scanning of the complex at 100. 
3.2 Particle size and zeta potential: The particle size and 
zeta potential can be determined by dynamic light scattering 
(DLS) using a computerized inspection system and photon 
correlation spectroscopy (PCS)(19). Size analysis and zeta 
potential Malvern Zeta sizer is used to check the particle size 
and zeta size of phytosomal complex. Argon laser is used for 
this particle size and zeta sizer characterization. 
3.3 Drug entrapment efficiency: The entrapment efficiency 
of a drug by phytosomes can be measured by the 
ultracentrifugation technique(20). Drug entrapment and 
loading capacityDrug phytosomal complex was centrifuged 
at 10000 rpm for 90 minutes at 4°C to separate phytosome 
from the untrapped drug. The concentration of free drug can 
be measured by doing ultraviolet spectroscopy. The 
percentage drug entrapment can be calculated as given 
formula: 
Entrapment efficiency % = Weight of total drug – weight 
of free drug / Weight of total drug×100 
3.4 Transition temperature: The transition temperature of 
the phytosomes can be determined by differential scanning 
calorimetry (21).  
3.5 Surface tension activity measurement: The surface 
tension activity of the drug in aqueous solution can be 
measured by the ring method in a Du Nouy ring tensiometer 
(22). 
 3.6 Vesicle stability: The stability of vesicles can be 
determined by assessing the size and structure of the 
vesicles over time. The mean size is measured by DLS and 
structural changes are monitored by TEM (23).  
3.7 Drug content: The amount of drug can be quantified by 
a modified high performance liquid chromatographic 
method or by a suitable spectroscopic method (24). 
3.8 spectroscopic evaluations  
To confirm the formation of a complex and interaction 
between the phytoconstituent and the phospholipids, the 
following spectroscopic methods are used (25).  
a) 1H NMR 
The NMR spectra of (+) catechin and its stoichiometric 
complex with distearoyl phosphatidylcholine have been 
studied by Bombardelli et al(26). In nonpolar solvents, there 
is a marked change of the 1HNMR signal originating from the 
atoms that is involved in the formation of the complex, 
without any summation of the signal peculiar to the 
individual molecules. The signals from the protons belonging 
to the flavonoids are to be broadened that the proton cannot 
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be relieved. In phospholipids, there is broadening of all the 
signals while the singlet corresponding to the N(CH3)3 of 
choline undergoes an up field shift. By heating the sample to 
60, the 1HNMR shows the appearance of some new broad 
bands, which correspond mainly to the resonance of the 
flavonoid moiety. 
b)   13CNMR 
In the 13CNMR spectrum of (+) catechin and its 
stoichiometric complex with distearoyl phosphatidylcholine, 
particularly when recorded in C6D6 at room temperature, all 
the flavonoid carbons are clearly invisible. The signals 
corresponding to the glycerol and choline portion of the lipid 
(between 60–80 ppm) are broadened and some are shifted, 
while most of the resonances of the fatty acid chains retain 
their original sharp line shape. After heating to 60, all the 
very broad and partially overlapping signals belonging to the 
flavonoid moieties reappear. 
c)FTIR 
The formation of the complex can be also be analysed by IR 
spectroscopy by comparing the spectrum of the complex 
with the spectrum of the individual components and their 
mechanical mixtures. FTIR spectroscopy is also a useful tool 
for the control of the stability of phytosomes when 
microdispersed in water or when incorporated in very 
simple cosmetic gels. FTIR analysis will be done for checking 
the structure as well as chemical stability of drug, 
phospholipid. The phytosomal drug will be crushed with 
potassium bromide to obtain pellets at 600 kg/cm2
 
pressure. Scanning will be done between the ranges of 4000-
400 cm-1. 
d) Differential scanning calorimeter 
Drug polyphenolic extract, phosphatidylcholine, a physical 
mixture of drug extract and Phosphatidylcholine, and drug-
phospholipid complex were placed in an aluminum cell and 
heated to a temperature of 50-250°C/minutes from 0 to 
400°C in the atmosphere of nitrogen. 
CONCLUSION 
This review is an attempt to present a concise profile of 
phytosomes as a delivery system. Phytosomes are advanced 
form of herbal extracts that are absorbed better than 
conventional herbal extracts. The article thus reviews the 
benefits, physical characteristics chemical properties and 
method of preparation of phytosomes. The formulation 
methodology for phytosomes is simple and can be easily 
upgraded to a commercial scale. 
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